Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-25-009079
Filing Date
2025-02-28
Accepted
2025-02-28 16:31:10
Documents
1
Period of Report
2025-02-27

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1740778263.html 4  
1 FORM 4 wk-form4_1740778263.xml 4 13649
  Complete submission text file 0001628280-25-009079.txt   15256
Mailing Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428
Business Address 200 BARR HARBOR DRIVE, SUITE 400 WEST CONSHOHOCKEN PA 19428 404-380-9263
MADRIGAL PHARMACEUTICALS, INC. (Issuer) CIK: 0001157601 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address INCYTE CORPORATION EXPERIMENTAL STATION RTE 141 & HENRY CLAY RD. BLDG E336 WILMINGTON DE 19880
Business Address
Daly James M (Reporting) CIK: 0001560782 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33277 | Film No.: 25690930